EU-SAFETY_HEALTH_WORK-PREAMBLE
EU-SAFETY_HEALTH_WORK-PREAMBLE
Safety and Health of Workers at Work Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)
This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.
RELEVANT LEGISLATION
Last updated 26 srpnja 2024. Database contains 4691 unique substances/entries.
Filter the list
|
200-240-8
|
55-63-0
|
Expl. 1.1; Acute Tox. 2; Acute Tox. 1; STOT RE 2 |
||
|
203-474-9
|
107-22-2
|
Muta. 2; Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
||
|
206-058-5
|
298-12-4
|
Eye Dam. 1; Skin Sens. 1B |
||
|
213-997-4
|
1071-83-6
|
Eye Dam. 1 |
||
|
617-243-9
|
81591-81-3
|
Acute Tox. 4 |
||
|
219-468-4
|
2439-99-8
|
Eye Dam. 1 |
||
|
201-964-7
|
90-05-1
|
Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2 |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
GUANIDINIUMBENZOAT
|
429-820-0
|
26739-54-8
|
Acute Tox. 4 |
|
|
200-002-3
|
50-01-1
|
Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2 |
||
|
620-427-1
|
108173-90-6
|
Acute Tox. 2; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1 |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
TILCOM HTB
|
411-740-2
|
22411-22-9
|
Eye Dam. 1; Skin Sens. 1 |
|
|
600-130-3
|
100784-20-1
|
Repr. 1B |
||
|
HALOXYFOP ETHOXYETHYL EST
|
402-560-5
|
87237-48-7
|
Acute Tox. 4 |
|
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
12035-71-1
|
Carc. 1A; Muta. 2; Acute Tox. 3; STOT RE 1; Skin Sens. 1 |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
200-962-3
|
76-44-8
|
Carc. 2; Acute Tox. 3; STOT RE 2 |
||
|
213-831-0
|
1024-57-3
|
Carc. 2; Acute Tox. 3; STOT RE 2 |
||
|
203-767-1
|
110-43-0
|
Flam. Liq. 3; Acute Tox. 4 |
||
|
203-388-1
|
106-35-4
|
Flam. Liq. 3; Acute Tox. 4; Eye Irrit. 2 |
||
|
204-608-9
|
123-19-3
|
Flam. Liq. 3; Acute Tox. 4 |
||
|
205-563-8
|
142-82-5
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
||
|
203-838-7
|
111-14-8
|
Skin Corr. 1B |
||
|
245-737-0
|
23560-59-0
|
Acute Tox. 3 |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
show/hide
|
247-148-4
|
25637-99-4
|
Repr. 2; Lact. |
|
|
204-129-5
|
116-16-5
|
Acute Tox. 4 |
||
|
204-273-9
|
118-74-1
|
Carc. 1B; STOT RE 1 |
||
|
201-029-3
|
77-47-4
|
Acute Tox. 2; Acute Tox. 3; Acute Tox. 4; Skin Corr. 1B |
||
|
show/hide
Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane
EC / List no:
271-555-6
| CAS no:
68585-32-0
Platinate(2-), hexachloro-, dihydrogen, (OC-6-11)-, reaction products with palladium
EC / List no:
-
| CAS no:
68516-04-1
Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with tributylphosphine hydrochloride and N-(3-(trimethoxysilyl)propyl)-1,2-ethanediamine
EC / List no:
-
| CAS no:
67924-25-8
Dihydrogen hexachloroplatinate, compound with 1,1,3,3-tetramethyl-1,3-divinyldisiloxane
EC / List no:
258-092-5
| CAS no:
52672-74-9
|
-
|
-
|
Acute Tox. 3; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
|
|
241-010-7
|
16941-12-1
|
Acute Tox. 3; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1 |
||
|
HEXACONAZOLE
|
413-050-7
|
79983-71-4
|
Acute Tox. 4; Skin Sens. 1 |
|
|
204-127-4
|
116-15-4
|
Press. Gas; Acute Tox. 4; STOT SE 3 |
||
|
256-356-4
|
48122-14-1
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
||
|
260-566-1
|
57110-29-9
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
||